These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 1863873)
1. Natural killer cells: immunobiology and clinical prospects. Lotzová E Cancer Invest; 1991; 9(2):173-84. PubMed ID: 1863873 [No Abstract] [Full Text] [Related]
2. Adoptive cellular immunotherapy of cancer. Winter H; Fox BA Curr Opin Mol Ther; 1999 Feb; 1(1):89-97. PubMed ID: 11249690 [No Abstract] [Full Text] [Related]
3. Immunotherapy with sensitized lymphocytes. Chang AE; Shu S Cancer Invest; 1992; 10(5):357-69. PubMed ID: 1393687 [No Abstract] [Full Text] [Related]
4. Tumor eradication by adoptive transfer of cytotoxic T lymphocytes. Melief CJ Adv Cancer Res; 1992; 58():143-75. PubMed ID: 1532109 [No Abstract] [Full Text] [Related]
5. Tumor-infiltrating lymphocytes from human solid tumors: antigen-specific killer T lymphocytes of activated natural killer lymphocytes. Whiteside TL; Heo DS; Takagi S; Herberman RB Immunol Ser; 1989; 48():139-57. PubMed ID: 2488318 [No Abstract] [Full Text] [Related]
7. The preparation of effector cells for use in the adoptive cellular immunotherapy of human cancer. Yannelli JR J Immunol Methods; 1991 May; 139(1):1-16. PubMed ID: 2040807 [No Abstract] [Full Text] [Related]
11. [Generation and activation of tumor-infiltrating lymphocytes (TIL) within the scope of lymphokine activated killer cell therapy (LAK-TIL therapy) in patients with advanced breast and ovarian carcinoma]. Mallmann P; Krebs D Gynakol Geburtshilfliche Rundsch; 1995; 35 Suppl 1():161-5. PubMed ID: 8672919 [TBL] [Abstract][Full Text] [Related]